Press Release

C3i Delivers Joint Presentation with a Top 10 Pharmaceutical Company during Oracle Life Sciences Forums in EMEA and USA

Princeton, NJ – April 20, 2010

<Princeton, NJ, April 2010> – C3i, the leader in technology services for the life sciences industry, delivered a joint presentation with one of its global top 10 pharmaceutical clients during the Oracle Life Sciences Forums in Europe and the USA.

“Successful Transition to Oracle Clinical/Remote Data Capture” presentation was delivered in a form of a case study describing the recent transition to Oracle Clinical Remote Data Capture 4.5.3 of this worldwide pharma company. Using high-level performance metrics, the presentation outlined the objectives of the company’s electronic data capture (EDC) implementation as well as the challenges encountered. The presenters discussed the importance of help desk support as a factor that would increase user satisfaction with EDC. With 100% internal help desk support, the client experienced needs for multiple languages, faster call resolution and lower costs. C3i was recognized as the reliable partner to meet those requirements and during the presentation specific examples of the supporting ecosystem including helpdesk support, user administration, and study close-out services were outlined in detail.

“C3i's understanding of the unique needs of site users combined with our client's desire to leverage the single point of contact model that C3i offers has resulted in a partnership that yields highly effective services as is illustrated by our high first call resolution and consistent customer satisfaction over 98%“- added Daniel Brunetti, Vice President Account Management who presented on behalf of C3i.

The Oracle Life Sciences Forums both in Europe and the USA, whose platinum sponsor was C3i, are a unique opportunity to network and learn about Oracle Health Sciences product development strategies as well as successful customer cases. An Oracle partner since 1998, C3i is sponsoring those forums for another consecutive year which serves as great chance to present its growing Oracle Clinical capabilities. Today, C3i supports more than 300,000 clinical end users worldwide helping sponsors to reduce their total cost of ownership and increase technology efficiency.

About C3i:
Headquartered in Morristown, New Jersey, C3i Inc. has global operations in the United States, India and Bulgaria. Their 900 employees provide systems implementation, technology training, multi-lingual help desk, hardware provisioning, and break/fix, asset management, and user/application administration services for pharmaceutical sales and clinical professionals worldwide. To learn more, visit www.c3i-inc.com